Industry News

Siemens Healthineers launches Corindus Vascular Robotics in India

Siemens Healthineers launches Corindus Vascular Robotics in India

CorPath GRX facilitates up to 20% reduction in radiation doses to patients.

India. Siemens Healthineers has now added in its portfolio an FDA-approved and CE-certified robotic system, CorPath GRX for coronary and peripheral vascular interventions in India.  The recent development will provide an enormous impetus to the Indian Healthcare sector. Tapping into the adjacent growth markets with great potential for future, the state-of-the-art technology has opened a new domain for advanced therapies business. The robotic system for minimally invasive procedures can help doctors to accurately control guide wires, catheters, balloon, or stent implants with virtual imaging. The physicians can control the operation with a separate controlling module and can prevent standing at the angiography table as usual to prevent from radiation.

There has been an increase in incidences of cardiovascular disease (CVDs), especially coronary heart diseases worldwide. With coronary diseases and diabetes becoming leading cause of mortality in India, the country is taking a lead towards becoming the world’s capital of coronary heart diseases. As per recent study, one in four deaths in India can be contributed to ischemic heart diseases whereas 80% of this burden can be attributed to the increasing prevalence of CVD risk factors including lifestyle changes and poor diet.

The ideal treatment for cardiovascular medical conditions such as heart diseases include complex procedure in the coronary arteries that require precise medical intervention for which the surgical robotics can aid significantly. The smart procedural automation with vascular robotics can lead to shorter operation time, quicker recovery, and better clinical outcomes. Adoption of surgical robots can help to address the key geographical challenges such as limited availability of specialists and corresponding clinical facilities for minimally invasive surgeries.

Siemens Healthineers products makes treatments minimally invasive using high quality imaging before and during medical interventions, which is now being complemented by precision, protection, and standardisation through robotic devices.

Addressing the launch of CorPath GRX, Head of Advanced Therapies, Siemens Healthineers, India said, “Together with our strong portfolio in medical imaging, digitalisation and artificial intelligence, we are creating significant synergies to advance therapy outcomes. The interplay of protection, precision and standardisation through robotic-assisted interventions will allow the cardiologists to perform complex procedures faster and better. This will allow specialists to improve procedural quality and expand precision medicine; thereby improving clinical outcomes for the patient.”

TechSci Research said, “With the rising occurrences of chronic diseases along with increasing geriatric population, the demand for minimally invasive surgeries with surgical robots will continue to grow. The adoption of surgical robots in different fields for better outcomes and quicker recovery has fuelled the global surgical robots market. The integration of artificial intelligence and machine learning with robotics will only add to the market growth.”

According to TechSci Research report, Global Surgical Robots Market By Component (Systems, Instruments and Accessories, Services), By Mechanism of Control (Computer Control, Direct Tele manipulator), By Application (Orthopaedic Surgery, Endometriosis, General Surgery, Neurosurgery, Thoracic Surgery, Colorectal Surgery, Gynaecology, Heart Surgery, Urologic Surgery and Others), By End User (Hospitals & Clinics and Ambulatory Surgical Centres), By Region, Competition, Forecast & Opportunities, 2025”, Global surgical robots market is expected to grow at a CAGR of 15% during the forecast period to reach USD 13 billion by 2025. The global surgical robot market is driven by the growing occurrences of degenerative and chronic diseases such as diabetes, CVD, among others. Additionally, associated benefits of surgical robots from both surgeons and patients’ perspectives are anticipated to propel the growth of market over the next five years. Furthermore, technological innovations & advancements and new product launches by the major manufacturers such as introduction of flexible and cost-effective robots are expected to foster the growth of market until 2025.

According to TechSci Research report, “United States Surgical Robotics Market By Component (Surgical Systems, Accessories, Services), By Surgery Type (Gynaecological Surgery, Urological Surgery, Neurosurgery, Orthopedic Surgery, General Surgery, Others), By End User (Hospitals, Ambulatory Surgery Centres, Others), By Region, Forecast & Opportunities 2025”, United States surgical robotics market is expected to witness a healthy CAGR during the forecast period. Key factors propelling the growth of this market include technological advancements and increasing requirement for automation in healthcare industry. The growing prevalence of chronic diseases and advantages of robotic-assisted surgery including minimization of invasiveness involved in surgical procedures is further supporting the growth of United States surgical robotics market. In addition to this, increasing demand for minimally invasive surgeries coupled with development of procedure specific robotic systems are expected to fuel the market growth in coming years. Also, more hospitals & ambulatory surgery centres are turning towards using surgical robots, which is supporting the growth of this market.

Relevant News